Tenofovir Alafenamide 25 MG

DRUG9 trials

Conditions

Antiviral Drug Adverse ReactionAntiviral TreatmentChronic Hepatitis BChronic Hepatitis CHBVHepatitis BHepatitis B, ChronicLiver Transplant Disorder

Early Phase 1

Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection

NCT04507607

Third Affiliated Hospital, Sun Yat-Sen UniversityAntiviral Treatment, Chronic Hepatitis B, Mother-to-child Block

Start: 2020-08-01End: 2021-06-30Target: 50Updated: 2020-12-22

Phase 1

Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B

CompletedNCT04629976

Nucorion Pharmaceuticals, Inc.Chronic Hepatitis B

Start: 2021-01-12End: 2022-12-28Updated: 2023-01-04

Phase 4

Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

NCT04201808

New Discovery LLCHepatitis B, Chronic

Start: 2021-05-01End: 2023-09-30Target: 100Updated: 2020-11-17

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

NCT04997564

Peking University First HospitalChronic Hepatitis B, Chronic Hepatitis C

Start: 2021-08-31End: 2023-12-31Target: 120Updated: 2021-08-09

Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant

NCT05063071

Fudan UniversityHBV, POST LIVER TRANSPLANT

Start: 2021-07-29End: 2022-12-29Target: 150Updated: 2021-09-30

Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection

Active, not recruitingNCT05410496

Taichung Veterans General HospitalChronic Hepatitis B, Safety Issues, Transplant Recipient

Start: 2021-06-22End: 2027-07-30Updated: 2026-05-04

Unknown Phase

Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance

NCT03566030

Yonsei UniversityAntiviral Drug Adverse Reaction, Hepatitis B

Start: 2018-09-01End: 2020-08-31Target: 300Updated: 2018-06-21

Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission

NCT04237376

New Discovery LLCHepatitis B, Chronic, Pregnancy Related

Start: 2019-04-09End: 2020-09-30Target: 600Updated: 2020-01-23

Tenofovir Alafenamide for HBV Prophylaxis in HBV(-) Liver Transplant Recipients With HBcAb+ Donors

NCT04703465

RenJi HospitalHBV, Liver Transplant Disorder

Start: 2021-04-01End: 2024-04-01Target: 30Updated: 2021-01-11

Related Papers

Vertical Transmission in Mothers Taking <scp>TAF</scp> With Exceptionally High Viral Load

Journal of Viral Hepatitis2025-02-151 citations